181 related articles for article (PubMed ID: 32634350)
1. Abandoning List Prices In Medicaid Drug Reimbursement Did Not Affect Spending.
Ippolito B; Levy JF; Anderson GF
Health Aff (Millwood); 2020 Jul; 39(7):1202-1209. PubMed ID: 32634350
[TBL] [Abstract][Full Text] [Related]
2. AMCP Guide to Pharmaceutical Payment Methods.
AMCP Task Force on Drug Payment Methodologies
J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
[TBL] [Abstract][Full Text] [Related]
3. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
4. The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.
Frank RG; Hicks A; Berndt ER
Med Care Res Rev; 2021 Oct; 78(5):585-590. PubMed ID: 32468959
[TBL] [Abstract][Full Text] [Related]
5. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
Academy of Managed Care Pharmacy
J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs' reimbursements.
Costa E; Santos C
Eur J Health Econ; 2022 Dec; 23(9):1497-1518. PubMed ID: 35192093
[TBL] [Abstract][Full Text] [Related]
7. Varying health care provider objectives and cost-shifting: the case of retail pharmacy in the US.
Brooks JM; Sorofman B; Doucette W
Health Econ; 1999 Mar; 8(2):137-50. PubMed ID: 10342727
[TBL] [Abstract][Full Text] [Related]
8. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
[TBL] [Abstract][Full Text] [Related]
9. Managed health care.
Curtiss FR
Am J Hosp Pharm; 1989 Apr; 46(4):742-63. PubMed ID: 2719053
[TBL] [Abstract][Full Text] [Related]
10. State prescription drug price Web sites: how useful to consumers?
Tu HT; Corey CG
Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
[TBL] [Abstract][Full Text] [Related]
11. State strategies to address medicaid prescription spending: negotiated pricing vs price transparency.
Noh S; Janousek CL; Park JH
Health Econ Policy Law; 2021 Apr; 16(2):201-215. PubMed ID: 32349843
[TBL] [Abstract][Full Text] [Related]
12. Who cares what it costs to dispense a Medicaid prescription?
Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
[TBL] [Abstract][Full Text] [Related]
13. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
[TBL] [Abstract][Full Text] [Related]
14. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
[TBL] [Abstract][Full Text] [Related]
15. State Medicaid pharmacy payments and their relation to estimated costs.
Adams EK; Kreling DH; Gondek K
Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
[TBL] [Abstract][Full Text] [Related]
16. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
Davidova J; Praznovcova L; Lundborg CS
Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
[TBL] [Abstract][Full Text] [Related]
17. Variation of prescription drug prices in community pharmacies: A national cross-sectional study.
Larkin J; Moriarty F; McGuinness S; Finucane K; Fitzgerald K; Smith SM; O'Mahony JF
Res Social Adm Pharm; 2022 Oct; 18(10):3736-3743. PubMed ID: 35618647
[TBL] [Abstract][Full Text] [Related]
18. Prescription Drug Price Paradox: Cost Analysis of Canadian Online Pharmacies versus US Medicare Beneficiaries for the Top 100 Drugs.
Kim SH; Ryu YJ; Cho NE; Kim AE; Chang J
Clin Drug Investig; 2017 Oct; 37(10):957-963. PubMed ID: 28735450
[TBL] [Abstract][Full Text] [Related]
19. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
20. Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.
Luo J; Avorn J; Kesselheim AS
JAMA Intern Med; 2015 Oct; 175(10):1681-6. PubMed ID: 26301721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
